Regulation of kidney development by Shp2: An unbiased stereological analysis

Anatomical Record

Volumn 293, Issue 12, 2010, Pages 2147-2153

  David, Frank S ^a   Cullen McEwen, Luise ^b   Wu, Xue Sue ^c   Zins, Stephen R ^d,e   Lin, Julie ^a   Bertram, John F ^b   Neel, Benjamin G ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MONASH UNIVERSITY   (Australia)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Kidney; Phosphatase; PTPN11; Shp2; Stereology

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE SHP 2;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS; HETEROZYGOSITY; IN VIVO STUDY; KIDNEY DEVELOPMENT; MALE; MOUSE; NEPHRON; NONHUMAN; ORGAN SIZE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; STEREOLOGY; WILD TYPE;

ANIMALS; FEMALE; GENE DOSAGE; HETEROZYGOTE; KIDNEY; KIDNEY GLOMERULUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRONS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

INVERTEBRATA; MUS;

EID: 78649706982     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21236     Document Type: Article

References (50)

1. Affolter M, Bellusci S, Itoh N, Shilo B, Thiery JP, Werb Z. 2003. Tube or not tube: remodeling epithelial tissues by branching morphogenesis. Dev Cell 4: 11-18.
2. Allard JD, Chang HC, Herbst R, McNeill H, Simon MA. 1996. The SH2-containing tyrosine phosphatase corkscrew is required during signaling by sevenless, Ras1 and Raf. Development 122: 1137-1146.
3. Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y. 2008. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat 29: 992-1006.
4. Araki T, Chan G, Newbigging S, Morikawa L, Bronson RT, Neel BG. 2009. Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation. Proc Natl Acad Sci USA 106: 4736-4741.
5. Basson MA, Akbulut S, Watson-Johnson J, Simon R, Carroll TJ, Shakya R, Gross I, Martin GR, Lufkin T, McMahon AP, Wilson PD, Costantini FD, Mason IJ, Licht JD. 2005. Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev Cell 8: 229-239.
6. Brenner BM, Chertow GM. 1994. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23: 171-175.
7. Brenner BM, Garcia DL, Anderson S. 1988. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1: 335-347.
8. Brenner BM, Mackenzie HS. 1997. Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 63: S124-127.
9. Cacalano G, Farinas I, Wang LC, Hagler K, Forgie A, Moore M, Armanini M, Phillips H, Ryan AM, Reichardt LF, Hynes M, Davies A, Rosenthal A. 1998. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21: 53-62.
10. Clark AT, Bertram JF. 1999. Molecular regulation of nephron endowment. Am J Physiol 276: F485-497.
11. Costantini F. 2006. Renal branching morphogenesis: concepts, questions, and recent advances. Differentiation 74: 402-421.
12. Cullen-McEwen LA, Caruana G, Bertram JF. 2005. The where, what and why of the developing renal stroma. Nephron Exp Nephrol 99: e1-e8.
13. Cullen-McEwen LA, Drago J, Bertram JF. 2001. Nephron endowment in glial cell line-derived neurotrophic factor (GDNF) heterozygous mice. Kidney Int 60: 31-36.
14. Cullen-McEwen LA, Kett MM, Dowling J, Anderson WP, Bertram JF. 2003. Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension 41: 335-340.
15. Davies JA, Fisher CE. 2002. Genes and proteins in renal development. Exp Nephrol 10: 102-113.
16. Fassi A, Sangalli F, Maffi R, Colombi F, Mohamed EI, Brenner BM, Remuzzi G, Remuzzi A. 1998. Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficit. J Am Soc Nephrol 9: 1399-1406.
17. Fisher CE, Michael L, Barnett MW, Davies JA. 2001. Erk MAP kinase regulates branching morphogenesis in the developing mouse kidney. Development 128: 4329-4338.
18. George CD, Patton MA, el Sawi M, Sharland M, Adam EJ. 1993. Abdominal ultrasound in Noonan syndrome: a study of 44 patients. Pediatr Radiol 23: 316-318.
19. Ghabrial A, Luschnig S, Metzstein MM, Krasnow MA. 2003. Branching morphogenesis of the Drosophila tracheal system. Annu Rev Cell Dev Biol 19: 623-647.
20. Herbst R, Zhang X, Qin J, Simon MA. 1999. Recruitment of the protein tyrosine phosphatase CSW by DOS is an essential step during signaling by the sevenless receptor tyrosine kinase. Embo J 18: 6950-6961.
21. Hoeffel JC, Juncker P, Delgoffe C, Pernot C. 1982. [Radiological anomalies in the Noonan syndrome (author's transl)]. Sem Hop 58: 1119-1122.
22. Hogan BL, Kolodziej PA. 2002. Organogenesis: molecular mechanisms of tubulogenesis. Nat Rev Genet 3: 513-523.
23. Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K, Bertram JF. 2003. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl: S31-S37.
24. Itoh M, Yoshida Y, Nishida K, Narimatsu M, Hibi M, Hirano T. 2000. Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol Cell Biol 20: 3695-3704.
25. Keller G, Zimmer G, Mall G, Ritz E, Amann K. 2003. Nephron number in patients with primary hypertension. N Engl J Med 348: 101-108.
26. Lore F, Di Cairano G, Talidis F. 2000. Unilateral renal agenesis in a family with medullary thyroid carcinoma. N Engl J Med 342: 1218-1219.
27. Lore F, Talidis F, Di Cairano G, Renieri A. 2001. Multiple endocrine neoplasia type 2 syndromes may be associated with renal malformations. J Intern Med 250: 37-42.
28. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver-Moore K, Rosenthal A. 1996. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76-79.
29. Neel BG, Gu H, Pao L. 2003. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28: 284-293.
30. Oliver J. 1968. Nephrons and kidneys; a quantitative study of developmental and evolutionary mammalian renal architectonics. New York: Hoeber Medical Division, Harper & Row.
31. Perkins LA, Johnson MR, Melnick MB, Perrimon N. 1996. The nonreceptor protein tyrosine phosphatase corkscrew functions in multiple receptor tyrosine kinase pathways in Drosophila. Dev Biol 180: 63-81.
32. Perkins LA, Larsen I, Perrimon N. 1992. Corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell 70: 225-236.
33. Pichel JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H. 1996. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 73-76.
34. Reichman-Fried M, Dickson B, Hafen E, Shilo BZ. 1994. Elucidation of the role of breathless, a Drosophila FGF receptor homolog, in tracheal cell migration. Genes Dev 8: 428-439.
35. Riggs W, Jr. 1970. Roentgen findings in Noonan's syndrome. Radiology 96: 393-395.
36. Royal I, Fournier TM, Park M. 1997. Differential requirement of Grb2 and PI3-kinase in HGF/SF-induced cell motility and tubulogenesis. J Cell Physiol 173: 196-201.
37. Sachs M, Brohmann H, Zechner D, Muller T, Hulsken J, Walther I, Schaeper U, Birchmeier C, Birchmeier W. 2000. Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol 150: 1375-1384.
38. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M. 1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382: 70-73.
39. Sariola H, Holm-Sainio K, Henke-Fahle S. 1989. The effect of neuronal cells on kidney differentiation. Int J Dev Biol 33: 149-155.
40. Schaeper U, Gehring NH, Fuchs KP, Sachs M, Kempkes B, Birchmeier W. 2000. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J Cell Biol 149: 1419-1432.
41. Schuchardt A, D'Agati V, Pachnis V, Costantini F. 1996. Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. Development 122: 1919-1929.
42. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. 2000. Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol 10: 147-154.
43. Skinner MA, Safford SD, Reeves JG, Jackson ME, Freemerman AJ. 2008. Renal aplasia in humans is associated with RET mutations. Am J Hum Genet 82: 344-351.
44. Sommerschild HC, Soerland SJ. 1974. Urinary tract malformations in Noonan's syndrome (XX, XY Turner phenotype). Z Kinderchir 14: 422-425.
45. Tang MJ, Cai Y, Tsai SJ, Wang YK, Dressler GR. 2002. Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase. Dev Biol 243: 128-136.
46. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. 2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29: 465-468.
47. Weidner KM, Di Cesare S, Sachs M, Brinkmann V, Behrens J, Birchmeier W. 1996. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384: 173-176.
48. Yang W, Klaman LD, Chen B, Araki T, Harada H, Thomas SM, George EL, Neel BG. 2006. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev Cell 10: 317-327.
49. Zhang Z, Quinlan J, Grote D, Lemire M, Hudson T, Benjamin A, Roy A, Pascuet E, Goodyer M, Raju C, Houghton F, Bouchard M, Goodyer P. 2009. Common variants of the glial cell-derived neurotrophic factor gene do not influence kidney size of the healthy newborn. Pediatr Nephrol 24: 1151-1157.
50. Zhang Z, Quinlan J, Hoy W, Hughson MD, Lemire M, Hudson T, Hueber PA, Benjamin A, Roy A, Pascuet E, Goodyer M, Raju C, Houghton F, Bertram J, Goodyer P. 2008. A common RET variant is associated with reduced newborn kidney size and function. J Am Soc Nephrol 19: 2027-2034.